James Investment Research’s Quest Diagnostics DGX Stock Holding History

James Investment Research’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-187	Closed	-$29K	–	591
2022 Q4	$29K	Buy	+187	New	+$26.9K	﹤0.01%	405
2020 Q1	–	Sell	-19	Closed	-$2K	–	489
2019 Q4	$2K	Hold	19	–	–	﹤0.01%	492
2019 Q3	$2K	Hold	19	–	–	﹤0.01%	553
2019 Q2	$2K	Hold	19	–	–	﹤0.01%	648
2019 Q1	$2K	Hold	19	–	–	﹤0.01%	800
2018 Q4	$2K	Hold	19	–	–	﹤0.01%	770
2018 Q3	$2K	Hold	19	–	–	﹤0.01%	779
2018 Q2	$2K	Sell	19 -18,860	-100%	-$1.96M	﹤0.01%	783
2018 Q1	$1.89M	Buy	18,879 +18,860	+99,263%	+$1.93M	0.07%	345
2017 Q4	$2K	Sell	19 -15,700	-100%	-$1.49M	﹤0.01%	755
2017 Q3	$1.47M	Buy	15,719 +15,700	+82,632%	+$1.67M	0.05%	412
2017 Q2	$2K	Hold	19	–	–	﹤0.01%	708
2017 Q1	$2K	Hold	19	–	–	﹤0.01%	642
2016 Q4	$2K	Hold	19	–	–	﹤0.01%	527
2016 Q3	$2K	Hold	19	–	–	﹤0.01%	529
2016 Q2	$2K	Buy	+19	New	+$1.45K	﹤0.01%	490

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

James Investment Research's DGX Position: Q1 2023 in Review

James Investment Research sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 187 shares — an estimated $29K sold.

James Investment Research first reported a position in DGX in Q2 2016 and held it in 16 quarters. The position peaked at $1.89M in Q1 2018. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

James Investment Research reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
James Investment Research sold 187 Quest Diagnostics shares in Q1 2023, an estimated $29K.
James Investment Research first reported a position in Quest Diagnostics in Q2 2016 and held it in 16 quarters.
James Investment Research's Quest Diagnostics position peaked at $1.89M in Q1 2018.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on James Investment Research's 13F filing for Q1 2023, filed 26 Apr 2023.